May 09, 2024
3 min watch
Save
VIDEO: Intravitreal implant for wet AMD shows positive results in three clinical trials
FORT LAUDERDALE, Fla. — In this Healio Video Perspective from the Retina World Congress, Pravin U. Dugel, MD, of Ocular Therapeutix, overviews clinical results for Axpaxli, an axitinib implant for wet age-related macular degeneration.
Dugel discussed promising data across three clinical trials.
“We have already randomized for the SOL-1 study, which is a pivotal phase 3 study, and we’re very excited to report further results in the near-term,” Dugel said.
Published by:
Sources/Disclosures
Collapse
Source:
Healio Interviews
Disclosures:
Dugel reports being the executive chair, president and CEO at Ocular Therapeutix.
Read more about